[1]
|
Nassereddine, S., Rafei, H., Elbahesh, E. and Tabbara, I. (2017) Acute Graft versus Host Disease: A Comprehensive Review. Anti-cancer Research, 37, 1547-1555. https://doi.org/10.21873/anticanres.11483
|
[2]
|
Flinn, A.M. and Gennerya, R. (2017) Treatment of Pediatric Acute Graft-versus-Host Disease-Lessons from Primary Immunodeficiency. Frontiers in Immunology, 8, 328. https://doi.org/10.3389/fimmu.2017.00328
|
[3]
|
Yang, J.-Z., Zhang, J.-Q. and Sun, L.-X. (2016) Mechanisms for T Cell Tolerance Induced with Granulocyte Colony-Stimulating Factor. Molecular Immunology, 70, 56-62. https://doi.org/10.1016/j.molimm.2015.12.006
|
[4]
|
王越. 调节性B细胞的免疫调控机制及其在移植物抗宿主病中的作用[J]. 海南医学, 2019, 30(6): 787-791.
|
[5]
|
Xiao, B., Wang, Y., Li, W., et al. (2013) Plasma microRNA Signature as a Noninvasive Biomarker for Acute Graft-versus-Host Disease. Blood, 122, 3365-3375. https://doi.org/10.1182/blood-2013-06-510586
|
[6]
|
Xie, L.N., Zhou, F., Liu, X.M., Fang, Y., Yu, Z., et al. (2014) Serum microRNA155 Is Increased in Patients with Acute Graft-versus-Host Disease. Clinical Transplantation, 28, 314-323. https://doi.org/10.1111/ctr.12314
|
[7]
|
Ranganathan, P., Heaphy, C.E., Costinean, S., Stauffer, N., Na, C., et al. (2012) Regulation of Acute Graft-versus-Host Disease by microRNA-155. Blood, 119, 4786-4797. https://doi.org/10.1182/blood-2011-10-387522
|
[8]
|
Wang, Y., Zhao, X., Ye, X., Luo, H.X., Zhao, T.F., et al. (2015) Plasma microRNA-586 Is a New Biomarker for Acute Graft-versus-Host Disease. Annals of Hematology, 94, 1505-1514. https://doi.org/10.1007/s00277-015-2414-z
|
[9]
|
胡彬, 付伟, 等. 异基因造血干细胞移植后血浆microRNA的表达与急性移植物抗宿主病的相关性研究[J]. 中国实验血液学杂志, 2016, 24(3): 827-832.
|
[10]
|
Zeng, L., Yan, Z., Ding, S., Xu, K. and Wang, L. (2008) Endothelial Injury, an Intriguing Effect of Methotrexate and Cyclophosphamide during Hematopoietic Stem Cell Transplantation in Mice. Transplantation Proceedings, 40, 2670-2673. https://doi.org/10.1016/j.transproceed.2008.06.038
|
[11]
|
Almici, C., Skert, C., Verardi, R., et al. (2014) Changes in Circulating En-dothelial Cells Count Could Become a Valuable Tool in the Diagnostic Definition of Acute Graft-versus-Host Disease. Transplantation, 98, 706-712.
https://doi.org/10.1097/TP.0000000000000385
|
[12]
|
Nakamura, Y., Tanaka, Y., Sugiyama, A., Yamamoto, K., et al. (2016) Soluble Interleukin-2 Receptor Index Predicts the Development of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation from Unrelated Donors. International Journal of Hematology, 103, 436-443. https://doi.org/10.1007/s12185-016-1936-z
|
[13]
|
Nelson, R.P., Khawaja, M.R., Perkins, S.M., Elmore, L., et al. (2014) Prognos-tic Biomarkers for Acute Graft-versus-Host Disease Risk after Cyclophosphamide-Fludarabine Nonmyeloablative Allotransplantation. Biology of Blood and Marrow Transplantation, 20, 1861-1864. https://doi.org/10.1016/j.bbmt.2014.06.039
|
[14]
|
唐伦, 颜红菊, 等. 异基因造血干细胞移植患者血清生物标志物水平变化与aGVHD的关系[J]. 中国输血杂志, 2016, 29(6): 598-601.
|
[15]
|
Okamoto, T., Takatsuka, H., Fujimori, Y., Wada, H., Iwasaki, T. and Kakishita, E. (2001) Increased Hepatocyte Growth Factor in Serum in Acute Graft-versus-Host Disease. Bone Marrow Transplant, 28, 197-200.
https://doi.org/10.1038/sj.bmt.1703095
|
[16]
|
Paczesny, S., Krijanovski, O.I., Braun, T.M., et al. (2009) A Biomarker Panel for Acute Graft-versus-Host Disease. Blood, 113, 273-278.
|
[17]
|
Pfundt, R., Wingens, M., Bergers, M., Zweers, M., Frenken, M. and Schalk-wijk, J. (2000) TNF-alpha and Serum Induce SKALP/elafin Gene Expression in Human Keratinocytes by a p38 MAP Ki-nase-Dependent Pathway. Archives of Dermatological Research, 292, 180-187. https://doi.org/10.1007/s004030050475
|
[18]
|
Paczesny, S., Braun, T.M., Levine, J.E., et al. (2010) Elafin Is a Biomarker of Graft-versus-Host Disease of the Skin. Science Translational Medicine, 2, 13ra2. https://doi.org/10.1126/scitranslmed.3000406
|
[19]
|
McDonald, G.B., Tabellini, L., Storer, B.E., Lawler, R.L., Martin, P.J. and Hansen, J.A. (2015) Plasma Biomarkers of Acute GVHD and Nonrelapse Mortality: Predictive Value of Measurements before GVHD Onset and Treatment. Blood, 126, 113-120. https://doi.org/10.1182/blood-2015-03-636753
|
[20]
|
Levine, J.E., Braun, T.M., Harris, A.C., et al. (2015) A Prognostic Score for Acute Graft-versus-Host Disease Based on Biomarkers: A Multicenter Study. The Lancet Haematology, 2, e21-e29.
https://doi.org/10.1016/S2352-3026(14)00035-0
|
[21]
|
Budde, H., Papert, S., Maas, J.-H., Reichardt, H.M., Wulf, G., et al. (2017) Prediction of Graft-versus-Host Disease: A Biomarker Panel Based on Lymphocytes and Cytokines. Annals of Hematology, 96, 1127-1133.
|
[22]
|
Schwinger, W., Weber-Mzell, D., Zois, B., et al. (2006) Immune Reconstitution after Purified Autologous and Al-logeneic Blood Stem Cell Transplantation Compared with Unmanipulated Bone Marrow Transplantation in Children. British Journal of Haematology, 135, 76-84. https://doi.org/10.1111/j.1365-2141.2006.06244.x
|
[23]
|
Zou, X., Lin, X., et al. (2016) Donor-Derived Regulatory T Cells Attenuate the Severity of Acute Graft-versus-Host Disease after Cord Blood Transplantation. The Tohoku Journal of Experimental Medicine, 239, 193-202.
|
[24]
|
Tvedt, T.H., Lie, S.A., et al. (2016) Pre-Transplant Levels of CRP and Interleukin-6 Family Cytokines; Effects on Outcome after Allogeneic Stem Cell Transplantation. International Journal of Molecular Sciences, 17, 1823.
https://doi.org/10.3390/ijms17111823
|